[pubmed] Comment on " Predictive factors for a severe course of COVID-19 infection in Myasthenia gravis patients with an
Posté : 29 sept. 2021 12:00
Eur J Neurol. 2021 Sep 29. doi: 10.1111/ene.15131. Online ahead of print.
ABSTRACT
We read with interest the report by Jakubíková et al [1] on predictive factors affecting myasthenia gravis (MG) and survival in severe COVID-19 patients in two centers of the Czech Republic. Although the study was certainly conducted with good methodology, our careful reading raised some points of discussion. First, we were impressed by the number of patients enrolled. The authors should provide information regarding the global incidence of COVID-19 in the Czech Republic and the prevalence of MG in the 2 centers of Prague and Brno during the pandemic .
PMID:34586695 | DOI:10.1111/ene.15131
Source: https://pubmed.ncbi.nlm.nih.gov/3458669 ... 9&v=2.15.0